- Albert Invent is a Bay Area-based software development company that provides an AI-enabled end-to-end platform designed to accelerate R&D in materials science and chemical innovation.
- In February 2025, Albert Invent secured $45 million in funding led by J.P. Morgan Private Capital to enhance its platform and further its mission of removing innovation barriers in laboratories worldwide.
- The company has formed a strategic partnership with Kenvue to streamline and accelerate R&D processes for consumer health products, leveraging Albert Invent's AI capabilities to enhance product development.
- Albert Invent's ideal buyers are R&D leaders in the chemical and consumer health sectors, as they address the pain points of fragmented workflows and slow product development cycles, making them a compelling option for organizations looking to innovate faster.
Albert Invent's workforce is organized into 11 departments, with the largest being Information Technology, which comprises 15 employees. Operations follows closely with a headcount of 10, while Sales includes 8 personnel. This distribution indicates a strong emphasis on IT and operational support, essential for a software development company, while also maintaining a balanced approach across other functional areas.
The company operates across 27 locations, with the highest concentrations in Pittsburgh, PA and Redwood City, CA, each housing 4 employees, followed by San Francisco, CA with 3. The presence of multiple locations suggests a distributed workforce model, allowing for flexibility and access to diverse talent pools. Additionally, the 'Other' category, which includes 28 locations, highlights a significant remote or less concentrated operational strategy.
